Larvol Delta - HOVON-172-MF-Tasquinimod-in-Patients-with-Myelofibrosis-Refractory-to-or-Intolerant-for-JAK2-Inhibition

tasquinimod (ABR-215050) - Active Biotech

http://clinicaltrials.gov/ct2/show/NCT06605586

Apr 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next